Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy-Reference-Cited by-同舟云学术

Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy

Published:2017-05-23 Issue:43 Volume:8 Page:74049-74057
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dietz Steffen¹,Sültmann Holger¹,Du YueJun²³,Reisinger Eva⁴,Riediger Anja Lisa⁵,Volckmar Anna-Lena⁶,Stenzinger Albrecht⁶,Schlesner Matthias⁷,Jäger Dirk⁵,Hohenfellner Markus²,Duensing Stefan⁸,Grüllich Carsten⁵,Pahernik Sascha²⁹

Affiliation:

1. Cancer Genome Research Group, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany

2. Department of Urology, Heidelberg University Hospital, Heidelberg, Germany

3. Department of Urology, Nanfang Hospital of Southern Medical University, Guangzhou, China

4. Data Management Group, Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), and Heidelberg Center for Personalized Oncology (DKFZ-HIPO), Heidelberg, Germany

5. Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany

6. Institute of Pathology, University Hospital Heidelberg, and German Cancer Consortium (DKTK), Heidelberg, Germany

7. Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany

8. Section of Molecular Urooncology, Department of Urology, Heidelberg University Hospital, Heidelberg, Germany

9. Department of Urology, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clear-cell papillary renal cell tumour: New insights into clinicopathological features and molecular landscape after renaming by 5th WHO classification;Pathology - Research and Practice;2024-03

2. Comprehensive Systematic Review of Biomarkers in Metastatic Renal Cell Carcinoma: Predictors, Prognostics, and Therapeutic Monitoring;Cancers;2023-10-11

3. Genomic analyses of renal cell carcinoma employing next generation sequencing;Die Onkologie;2023-06-15

4. Antineoplastics;Reactions Weekly;2023-04-29

5. Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities;Frontiers in Oncology;2022-05-10